The major strength of our study is the detailed analysis of the serum levels of lipoprotein subclasses in HVs and patients with MS, which enabled a comprehensive analysis of the associations between the lipoprotein parameters and adiponectin in the study groups. This evidence concerns the gene ADIPOQ and myeloid sarcoma.